Discontinued — last reported Q3 '25
Non-Current Assets
Intangibles (Net)
Revolution Medicines, Inc. Intangibles (Net) remained flat by 0.0% to $55.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $56.40M to $55.80M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows relatively stable performance with a -1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
Detailed definition
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Peer comparison
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
Metric ID:
intangible_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $60.41M | $60.14M | $59.88M | $59.61M | $59.34M | $59.08M | $58.81M | $58.54M | $58.27M | $58.01M | $57.74M | $57.47M | $57.21M | $56.94M | $56.67M | $56.40M | $56.14M | $55.87M | $55.80M | $55.80M |
| QoQ Change | — | -0.4% | -0.4% | -0.4% | -0.4% | -0.4% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.1% | +0.0% |
| YoY Change | — | — | — | — | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.8% | -1.9% | -1.9% | -1.9% | -1.9% | -1.5% | -1.1% |
Range$55.80M – $60.41M
CAGR-1.7%
Avg YoY Growth-1.8%
Median YoY Growth-1.8%
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s intangibles (net)?
- Revolution Medicines, Inc. (RVMD) reported intangibles (net) of $55.80M in Q1 2026.
- How has Revolution Medicines, Inc.'s intangibles (net) changed year-over-year?
- Revolution Medicines, Inc.'s intangibles (net) decreased by 1.1% year-over-year, from $56.40M to $55.80M.
- What is the long-term trend for Revolution Medicines, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s intangibles (net) has grown at a -1.7% compound annual growth rate (CAGR), from $60.95M to $55.80M.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brands after accounting for amortization.